Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer, semaglutide a potential treatment for serious weight gain from ALK tyrosine kinase inhibitors
These extensive, global, multi-year studies were designed to rigorously assess whether oral semaglutide could decelerate the progression of early stage symptomatic AD in over 3,800 participants (Scheltens et al., 2026)
In melanoma patients refractory to antiPD-1 therapy, the combination of Talimogene laherparepvec (T-VEC), an oncolytic herpesvirus, with pembrolizumab (NCT04068181) showed enhanced systemic immune activation and tumor response
US Food and Drug Administration) have now removed such warnings, the Therapeutic Goods Administration has updated product safety warnings and advised healthcare professionals to monitor people for changes in mood, behaviour or emerging suicidal thoughts or behaviours
Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function
The most successful users treat semaglutide as a tool that makes good dietary habits easier to follow, not as a replacement for them
